Global

U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak

Tue, 2022-10-18 18:38 — mike kraft

U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak The United States sent Gilead Sciences' remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda last week to help safeguard healthcare workers responding to an outbreak that has infected 60 people and killed 44, U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak
Log in or register to post comments

An addiction drug, Naltrexone, shows promise in countering long COVID brain fog, fatigue

Tue, 2022-10-18 10:22 — mike kraft

Addiction drug shows promise lifting long COVID brain fog, fatigue Lauren Nichols, a 34-year-old logistics expert for the U.S. Department of Transportation in Boston, has been suffering from impaired thinking and focus, fatigue, seizures, headache and pain since her COVID-19 infection in the spring of 2020. Julie Steenhuysen Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about An addiction drug, Naltrexone, shows promise in countering long COVID brain fog, fatigue
Log in or register to post comments

A variety of variants could fuel a winter COVID surge

Tue, 2022-10-18 09:47 — mike kraft

XBB, BQ.1.1, BA.2.75.2 — a variant swarm could fuel a winter surge Multiple versions of the omicron variant, including XBB and BQ.1.1, threaten to knock out treatments and challenge vaccines this winter. Carolyn Y. Johnson Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Read more about A variety of variants could fuel a winter COVID surge
Log in or register to post comments

Public Trust Crucial to Reponses to Health Crisis--study

Tue, 2022-10-18 09:29 — mike kraft

Public Trust Can Make or Break Government Response to Public Health Crisis Global Health NOW

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Public Trust Crucial to Reponses to Health Crisis--study
Log in or register to post comments

Trump administration blocked CDC transit mask mandate--Congressional comittee

Mon, 2022-10-17 17:34 — mike kraft

Trump administration blocked CDC transit mask mandate, report shows Former President Donald Trump's administration at a crucial time in the COVID-19 pandemic in 2020 blocked the U.S. Centers for Disease Control and Prevention (CDC) from adopting a federal mandate requiring face masks on airline flights and other forms of transit, a congressional report released on Monday said. David Shepardson Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Trump administration blocked CDC transit mask mandate--Congressional comittee
Log in or register to post comments

Moderna CEO predicts that not everyone will need an annual COVID booster

Mon, 2022-10-17 14:50 — mike kraft

Moderna CEO: Not everyone will need an annual COVID booster Moderna CEO says not everyone will need an annual COVID booster. YahooFinance

The COVID-19 booster market is starting to look more like an annual flu season than it did in the first two years of the pandemic.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Moderna CEO predicts that not everyone will need an annual COVID booster
Log in or register to post comments

Ebola: Uganda locks down two districts, Indian company to produce an experimental vaccine for Uganda's outbreak

Mon, 2022-10-17 14:24 — mike kraft

Uganda locks down 2 districts in bid to stem spread of Ebola KAMPALA, Uganda (AP) — Ugandan authorities on Saturday imposed a travel lockdown on two Ebola-hit districts as part of efforts to stop the spread of the contagious disease. The measures announced by President Yoweri Museveni mean residents of the central Ugandan districts of Mubende and Kassanda can't travel into or out of those areas by private or public means. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Analysis: COVID has splintered into multiple variants dominating different countries at the same time.

Mon, 2022-10-17 08:50 — mike kraft

COVID has splintered into multiple variants dominating different countries at the same time. Experts say these are some scenarios could play out It wasn’t so long ago that any COVID variant that hit the U.K. was headed to the U.S. in short order. But now the variant—or swarm of variants—to next plague North America is anyone’s best guess. Fortune

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Analysis: Africa's progress and challenges in confronting pandemics--report

Fri, 2022-10-14 19:18 — mike kraft

Africa: Ready to Respond | Think Global Health The changing story of a vulnerable continent better prepared to respond to pandemics Council on Foreign Relations

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis: Africa's progress and challenges in confronting pandemics--report
Log in or register to post comments

Key Cholara vaccine production to be discontinued, causing official dismay

Fri, 2022-10-14 17:43 — mike kraft

Dismay as key cholera vaccine is discontinued Exclusive: halt to production of Shanchol vaccine alarms WHO amid ‘unprecedented’ global outbreaks the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Key Cholara vaccine production to be discontinued, causing official dismay
Log in or register to post comments

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Global

U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak

An addiction drug, Naltrexone, shows promise in countering long COVID brain fog, fatigue

A variety of variants could fuel a winter COVID surge

Public Trust Crucial to Reponses to Health Crisis--study

Trump administration blocked CDC transit mask mandate--Congressional comittee

Moderna CEO predicts that not everyone will need an annual COVID booster

Ebola: Uganda locks down two districts, Indian company to produce an experimental vaccine for Uganda's outbreak

Analysis: COVID has splintered into multiple variants dominating different countries at the same time.

Analysis: Africa's progress and challenges in confronting pandemics--report

Key Cholara vaccine production to be discontinued, causing official dismay

Pages

User login

Search form

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Global

Pages